Furthermore, and importantly, we anticipate that VU0542270 or its optimized analogs will be useful for probing the therapeutic potential of vascular KATP channels in treating PDA, Cantu syndrome, migraine headache, and vascular collapse in sepsis without potentially confounding effects of inhibiting pancreatic and brain Kir6.2/SUR1 channels. This evidence concerns the gene KCNJ11 and Sepsis.